ClinicalTrials.Veeva

Menu

The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System

N

National Defense Medical Center, Taiwan

Status

Not yet enrolling

Conditions

Electrocardiogram
Cost-effectiveness Analysis
OMI - Occlusion Myocardial Infarction
Artificial Intelligence (AI)

Treatments

Other: AI-ECG P4P program

Study type

Interventional

Funder types

Other

Identifiers

NCT06887699
A202505035

Details and patient eligibility

About

This trial will prospectively evaluate the impact of integrating AI-ECG within the pay-for-performance program on improving the diagnosis, treatment, and clinical outcomes of occlusion myocardial infarction patients by promoting accurate and timely diagnoses through financial incentives.

Full description

The investigators have developed an AI-ECG system that provides real-time notifications for patients with potential occlusion myocardial infarction. This AI algorithm is seamlessly integrated into the Hospital Information System, allowing for the automatic generation of reports whenever an ECG is performed. The purpose of this study is to evaluate the impact of AI-ECG on the timely diagnosis of STEMI, including patients' outcomes and healthcare costs.

Enrollment

212,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients in the emergency department
  • Patients received at least 1 ECG examination.

Exclusion criteria

  • The patients received ECG at the period of inactive AI-ECG system.
  • Patients with a history of coronary angiography within the past 3 days.

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

212,000 participants in 2 patient groups

AI-ECG P4P program
Experimental group
Description:
AI-ECG-assisted detection of OMI within the P4P program. The AI-ECG system will conduct a real-time analysis of the ECG. When the system identifies potential OMI cases, it will immediately send short message service notifications to the on-duty cardiologists. This will enable the cardiologists to promptly review and confirm the diagnosis.
Treatment:
Other: AI-ECG P4P program
Standard of care
No Intervention group
Description:
Potential OMI patients will be initially assessed by frontline physicians. If OMI is suspected, the frontline physicians will promptly notify the on-duty cardiologists, who will then review the case for confirmation.

Trial contacts and locations

1

Loading...

Central trial contact

Chin Lin, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems